Abstract
“Duration of Deep Molecular Response” Has Most Impact on the Success of Cessation of Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukemia - Results from the EURO-SKI Trial
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have